BTF3P8

Across TCGA pan-cancer cohorts, BTF3P8 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated BTF3P8 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher BTF3P8 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BTF3P8 expression acts as an unfavorable survival marker, although some lineages such as CESC and KIRC show a favorable association.

OV, STAD, and CESC are the cancer types where BTF3P8 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Quartile	All	0.241	0.372	.003	48	view →
STAD	DFS	Median	III,IV	0.364	0.587	.013	37	view →
CESC	OS	Tertile	All	0.707	0.496	.011	24	view →
KIRC	DFS	Median	III,IV	0.542	0.395	.014	22	view →
MESO	DFS	Tertile	II,III,IV	0.679	0.359	.016	21	view →
LIHC	OS	Quartile	All	0.388	0.548	.001	21	view →
KICH	OS	Quartile	II,III,IV	0.700	0.938	.014	19	view →
ACC	DFS	Median	II,III,IV	0.277	0.676	.002	17	view →
UCS	DFS	Tertile	IV	0.981	0.621	.042	12	view →
ESCA	DFS	Tertile	II,III,IV	0.417	1.000	.022	10	view →
PAAD	OS	Tertile	All	0.315	0.519	.047	6	view →
SKCM	OS	Tertile	III,IV	0.911	0.773	.004	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

BTF3P8–OV (OS)

Open the OV breakdown →